Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study
阿帕替尼联合卡培他滨(希罗达)与卡培他滨(希罗达)作为晚期三阴性乳腺癌三线治疗的比较:一项回顾性研究
期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000012222
Li, Yi-Hui; Zhou, Yang; Wang, Yu-Wei; Tong, Ling; Jiang, Run-Xue; Xiao, Lei; Zhang, Guang-Ju; Xing, Shu-Shan; Qian, Fang; Feng, Jing-Qi; Zhao, Ya-Ling; Wang, Jian-Gong; Wang, Xiao-Hong